Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

A new tool about chemical contaminants in human and animal foods is available from the FDA. The Chemical Contaminants Transparency Tool is the latest ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

The FDA unveiled the Chemical Contaminants Transparency Tool, a searchable online database that provides a list of chemical ...

The U.S. Food and Drug Administration on Thursday launched an online searchable database listing contaminant levels in human ...

AHA comments regarding the Drug Enforcement Administration’s proposed rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations.

Despite a federal judge ordering deportation flights of Venezuelans to cease, video shows more deportees arriving in El ...

Punjab Police conducted raids at 424 locations on Sunday as part of the campaign against drugs, leading to the arrest of 63 drug smugglers after the registration of 45 first information reports (FIRs) ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...